Combined DNA and Protein ‘Liquid Biopsy’ for Early Pancreatic Cancer Better Than Either Alone

Reading Time: 1 minutes

Johns Hopkins scientists say they have developed a blood test that spots tumor-specific DNA and protein biomarkers for early-stage pancreatic cancer. The combined “liquid biopsy” identified the markers in the blood of 221 patients with the early-stage disease.

Leave a Reply

Your email address will not be published. Required fields are marked *